DRD2 and breast cancer: We then compared the responses to treatment with quinpirole, a dopamine receptor D2 (D2R)‐specific agonist, with those to treatment with aripiprazole in MCF‐7 cells to determine whether the underlying mechanism of aripiprazole‐induced apoptosis in breast cancer cells involved D2R signaling.